/Companies

Allotera Therapeutics

St. Louis, US · 7 known investors

Find your way into Allotera Therapeutics

Sign up to see every warm intro you have to Allotera Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Allotera Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Allotera is a pivotal-stage biotechnology company developing allogeneic, off-the-shelf CAR-T cell therapies derived from healthy donor cells to treat hematologic malignancies. The company operates US-based manufacturing built for scale and consistency.

Investors · 7

Frequently asked questions

What does Allotera Therapeutics do?
Allotera is a pivotal-stage biotechnology company developing allogeneic, off-the-shelf CAR-T cell therapies derived from healthy donor cells to treat hematologic malignancies. The company operates US-based manufacturing built for scale and consistency.
Who are Allotera Therapeutics's investors?
Allotera Therapeutics's investors include Aisling Capital, BioGenerator Ventures, LYZZ Capital, Abingworth, Alexandria, Fidelity Investments, RiverVest Venture Partners.
Where is Allotera Therapeutics headquartered?
Allotera Therapeutics is headquartered in St. Louis, US.